TuisSHTDY • OTCMKTS
add
Sinopharm Group ADR
Vorige sluiting
$12,21
Dagwisseling
$12,21 - $12,23
Jaarwisseling
$10,54 - $15,26
Markkapitalisasie
59,76 mjd HKD
Gemiddelde volume
24,18 k
P/V-verhouding
-
Dividend-opbrengs
-
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 144,38 mjd | -2,09% |
Bedryfskoste | 6,36 mjd | -6,80% |
Netto inkomste | 2,00 mjd | -12,11% |
Netto winsgrens | 1,39 | -9,74% |
Wins per aandeel | — | — |
EBITDA | 5,65 mjd | -6,41% |
Effektiewe belastingkoers | 27,77% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 47,16 mjd | 8,83% |
Totale bates | 420,17 mjd | -2,19% |
Totale aanspreeklikheid | 290,70 mjd | -5,36% |
Totale ekwiteit | 129,47 mjd | — |
Uitstaande aandele | 3,12 mjd | — |
Prys om te bespreek | 0,47 | — |
Opbrengs op bates | 2,71% | — |
Opbrengs op kapitaal | 5,26% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 2,00 mjd | -12,11% |
Kontant van bedrywe | 164,40 m | -97,47% |
Kontant van beleggings | -1,15 mjd | 11,27% |
Kontant van finansiering | 2,70 mjd | 548,42% |
Netto kontantverandering | 1,71 mjd | -62,83% |
Beskikbare kontantvloei | -9,01 mjd | — |
Meer oor
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Gestig
2003
Webwerf
Werknemers
100 251
